Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Perioperative S-1 Plus Oxaliplatin Combined With Serplulimab or Placebo for Locally Advanced Gastric Adenocarcinoma With Proficient Mismatch Repair: a Prospective, Multi-center, Double-blinded, Randomized Placebo-controlled Study

NCT05872685 is registered in ClinicalTrials.gov with Yu jiren as lead sponsor.

NCT NCT05872685
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05872685 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Perioperative S-1 Plus Oxaliplatin Combined With Serplulimab or Placebo for Locally Advanced Gastric Adenocarcinoma With Proficient Mismatch Repair: a Prospective, Multi-center, Double-blinded, Randomized Placebo-controlled Study
Lead sponsor
Yu jiren
Phase
Phase 2
Overall status
Recruiting
Start date
December 24, 2023
Completion date
April 30, 2029
Enrollment
314 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of esophagogastric junction, adenocarcinoma of the stomach, proficient mismatch repair